| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |